Predictors Of Long-Term Survival In Patients With Dlbclhgbcl Following Autosct
1:16
240
Predictors Of Long-Term Survival In Patients With Dlbclhgbcl Following Autosct
Hgbcl
24:11
9
Hgbcl
Updated Results Of Glofitamab Plus Polatuzumab Vedotin Combination Therapy In Dlbcl Including Hgbcl
2:54
342
Updated Results Of Glofitamab Plus Polatuzumab Vedotin Combination Therapy In Dl
Extended Follow-Up Of Glofitamab With Polatuzumab In Heavily Pre-Treated Rr Lbcl Including Hgbcl
2:02
58
Extended Follow-Up Of Glofitamab With Polatuzumab In Heavily Pre-Treated Rr Lbcl
Advanced Treatment For Large B-Cell Lymphoma Excerpt From Marias Story
0:49
108.763
Advanced Treatment For Large B-Cell Lymphoma Excerpt From Marias Story
High Grade Diffuse Large B-Cell Lymphoma Caroles Story
6:35
36.752
High Grade Diffuse Large B-Cell Lymphoma Caroles Story
What Is Double Hit Lymphoma? - Icml 2019
2:02
234
What Is Double Hit Lymphoma? - Icml 2019
Evaluating Myc Bcl2 And Bcl6 Expression To Define Double-Expressor Lymphoma
1:31
1.497
Evaluating Myc Bcl2 And Bcl6 Expression To Define Double-Expressor Lymphoma
Diffuse Large B-Cell Lymphoma Dlbcl - Aggressive B-Cell Neoplasm - Non-Hodgkins Lymphoma
8:21
159.724
Diffuse Large B-Cell Lymphoma Dlbcl - Aggressive B-Cell Neoplasm - Non-Hodgkins
Bms Breyanzi Receives Ec Approval For Rr Large B-Cell Lymphoma Post One Prior Therapy
1:17
130
Bms Breyanzi Receives Ec Approval For Rr Large B-Cell Lymphoma Post One Prior Th
Treatment Options For Dlbcl
54:13
104
Treatment Options For Dlbcl
Using Ai To Predict The Outcomes Of Patients With Rr Dlbcl Treated With Tisagenlecleucel
1:57
81
Using Ai To Predict The Outcomes Of Patients With Rr Dlbcl Treated With Tisagenl
Novel Immunotherapies Car T Bispecifics And Adcs - Jeremy Abramson Md
27:47
939
Novel Immunotherapies Car T Bispecifics And Adcs - Jeremy Abramson Md
How Does Your Dlbcl Subtype Impact Your Treatment Options?
3:37
80
How Does Your Dlbcl Subtype Impact Your Treatment Options?
Association Of Interim Pet2 Response With Outcomes In Patients With Dlbcl
2:35
169
Association Of Interim Pet2 Response With Outcomes In Patients With Dlbcl
Evaluating Salvage Radiotherapy In Patients With Dlbcl
1:11
185
Evaluating Salvage Radiotherapy In Patients With Dlbcl
Soho Saudi Arabia 2024 Day 1 - Dr Abdulwahab Albabtain
27:31
10
Soho Saudi Arabia 2024 Day 1 - Dr Abdulwahab Albabtain
Pet2-Assoicated Outcomes In Patients With Dlbcl
1:51
138
Pet2-Assoicated Outcomes In Patients With Dlbcl